Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Managing recurrent Clostridium difficile infection (CDI) is difficult for clinicians and patients. Fecal microbiota transplantation (FMT) is effective for recurrent CDI, but a standardized product is lacking (1)
It is a non-randomized, prospective, multicenter open-label, clinical phase II treatment trial studying RBX2660 via enema in 40 patients (enrolled) with ≥2 Clostridioides difficile infection (CDI) (recurrent) episodes leading to hospitalization (1).
Safety